September 5, 2017
Takeda Pharmaceutical said on September 4 that it has inked a collaboration deal with a Tokyo-based startup Noile-Immune Biotech on what they claim to be next-generation chimeric antigen receptor T (CAR-T) cell therapy for solid tumors. The deal was concluded...read more